Impact of Real-World Response to First-Line Immunotherapy and Chemotherapy on Subsequent Treatment Outcomes in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
{{output}}
Purpose: This study examined real-world overall survival (rwOS) in patients with advanced or metastatic non-small cell lung cancer (a/mNSCLC) treated with combination immunotherapy (IO) and platinum chemotherapy in first line (1L... ...
